Immunome, Inc. (IMNM)
23.88
+1.47
(+6.56%)
USD |
NASDAQ |
Jan 20, 16:00
23.71
-0.17
(-0.71%)
Pre-Market: 08:52
Immunome Shareholders Equity (Quarterly): 263.92M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Amphastar Pharmaceuticals, Inc. | 776.75M |
| Relay Therapeutics, Inc. | 607.71M |
| Prelude Therapeutics, Inc. | 58.53M |
| Context Therapeutics, Inc. | 73.17M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 299.38M |
| Total Liabilities (Quarterly) | 35.46M |
| Debt to Equity Ratio | 0.0152 |
| Current Ratio | 8.902 |
| Net Debt Paydown Yield | -0.02% |